J Control Release 2020 Jan 21
A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice.
Guo Q, Xu S, Yang P, Wang P, Lu S, Sheng D, Qian K, Cao J, Lu W, Zhang Q
The presence of blood-brain barrier (BBB) and specificity of neuron targeting remain two challenges in the effective delivery of nanotherapeutics for ...
Read More
Source: PubMed
Soc Sci Med
Is another relationship possible? Connoisseurship and the doctor-patient relationship for men who consume performance and image-enhancing drugs.
Fraser S, Fomiatti R, Moore D, Seear K, Aitken C
Consumption of steroids and other performance and image-enhancing drugs (PIEDs) is thought to be on the rise in Australia. Along with the benefits exp ...
Read More
Source: PubMed
Eur J Pharm Sci
A new cocrystal of isoniazid-quercetin with hepatoprotective effect: The design, structure, and in vitro/in vivo performance evaluation.
Liu F, Wang LY, Yu MC, Li YT, Wu ZY, Yan CW
With the purpose of overcoming the serious hepatotoxicity of antituberculosis drug isoniazid (INH), a cocrystallization strategy based on complementar ...
Read More
Source: PubMed
BMC Public Health
Study protocol for Goodform - a classroom-based intervention to enhance body image and prevent doping and supplement use in adolescent boys.
Doley JR, McLean SA, Griffiths S, Yager Z
Very few programs aimed at improving body image among adolescent boys have been effective, and there is still no clear evidence as to what will work f ...
Read More
Source: PubMed
Drug Test Anal 2020 Jan 10
Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
Börjesson A, Lehtihet M, Andersson A, Dahl ML, Vicente V, Ericsson M, Ekström L
The use of anabolic androgenic steroids (AAS) and other performance enhancing substances can change over time, so there is a need to constantly update ...
Read More
Source: PubMed
